Form Type: 4

SEC EDGAR Link
Accession Number:0000899243-23-008409
Date:2023-03-10
Issuer: AKERO THERAPEUTICS, INC. (AKRO)
Original Submission Date:

Reporting Person:

WHITE WILLIAM RICHARD
C/O AKERO THERAPEUTICS, INC.
601 GATEWAY BOULEVARD, SUITE 350 SOUTH SAN FRANCISCO, CA 94080

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK 2023-03-10 F 641 d $43.47 22,983 direct
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
Footnotes
IDfootnote
f1 represents shares required to be sold to satisfy tax withholding obligations of the reporting person related to the vesting of restricted stock units.
WhaleWisdom Logo

Elevate your investments